X4 Pharmaceuticals Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.64

+0.47 (+11.27%)

As of Aug 8, 10:26 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +512.5% upside

Low Target $21.41

Average Target $28.42

High Target $38.37

Current Price $4.64

Current
$4.64

Target
$28.42

$21.41 $28.42 avg $38.37

Scenario Analysis

Bear Case

$21.41

361.4%

Low target

Base Case

$28.42

+512.5%

Avg target

Bull Case

$38.37

+726.9%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$4.83

-3.9% from high

52-Week Low

$1.35

+243.7% from low

Target vs 52W High

$28.42

+488.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%